Mydecine Innovations Group (MYCOF) Short Interest Ratio & Short Volume

Short interest is the volume of Mydecine Innovations Group shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 300 shares of MYCOF short. Learn More on Mydecine Innovations Group's current short interest.

Mydecine Innovations Group saw a drop in short interest in October. As of October 31st, there was short interest totaling 300 shares, a drop of 89.7% from the previous total of 2,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Mydecine Innovations Group: Coca-Cola Europacific Partners PLC (1.14%), Coca-Cola FEMSA, S.A.B. de C.V. (1.34%), Fomento Económico Mexicano, S.A.B. de C.V. (1.05%), Celsius Holdings, Inc. (12.22%), Primo Water Co. (2.85%), Zevia PBC (1.72%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

Short selling MYCOF is an investing strategy that aims to generate trading profit from Mydecine Innovations Group as its price is falling. MYCOF shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Mydecine Innovations Group occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MYCOF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MYCOF, twice per month. The most recent reporting period available is October, 31 2024.